Purchase Order 36C24923P0827
- Not listed
- This is a $181,965.00 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Therakos, Inc., a foreign-owned, for-profit corporation specializing in photopheresis medical technology and pharmaceutical products. The contract is for the emergency purchase of Therakos Photopheresis Kits to support immediate patient care. The contract is not set-aside and has an ultimate completion date of February 5, 2016. Therakos, Inc. holds...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Therakos, Inc., a foreign-owned, for-profit corporation that specializes in photopheresis medical technology and pharmaceutical products. The contract, valued at $165,330.00, is for the provision of photopheresis kits required for the photopheresis machine used in patient care. The contract does not have a set-aside designation and has an ultimate completion date of May 1, 2016. Therakos,...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order to Therakos, Inc., a foreign-owned for-profit organization, to provide photopheresis kits. The $942,580.00 contract has a performance period ending on October 25, 2018 and was awarded on October 26, 2017. Therakos will deliver the photopheresis system kits, UVADEX medication, and associated supplies to VA medical facilities in Tennessee to support veteran healthcare programs....
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 9 (VISN 9) of the Department of Veterans Affairs (VA) to Therakos, Inc., a foreign-owned, for-profit corporation, for the provision of photopheresis kits and supplies. The contract has a ceiling value of $304,542.00 and a period of performance ending on September 30, 2021. Therakos, Inc. is the prime contractor, and there are no major subcontractors mentioned. The contract supports the VA's healthcare...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded Therakos, Inc., a foreign-owned for-profit company, a $316,030.86 firm fixed-price purchase order contract to provide photopheresis procedural kits and supplies. The contract, which has no set-aside designation, supports veteran healthcare programs through the delivery of photopheresis system kits, UVADEX medication, and associated supplies to VA medical facilities. This contract award is part of Therakos' larger...
- This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Therakos, Inc., a foreign-owned, for-profit corporation that specializes in photopheresis medical technology and pharmaceutical products. The contract, valued at $192,885.00, is for the procurement of CELLEX Procedural Kits. The contract is a Firm Fixed Price Purchase Order with a period of performance ending on August 31, 2016. The contract does not have a set-aside...
- This is a federal contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Therakos, Inc., a foreign-owned, for-profit corporation, to provide Therakos Cellex Photopheresis System procedural kits and light assemblies. The contract, valued at $492,732.00, is a firm fixed-price Purchase Order with economic price adjustment, awarded on November 1, 2018 with a completion date of July 30, 2021. The contract is for the supply of photopheresis system disposables and...
- This federal contract award is for a Blanket Purchase Agreement (BPA) order between the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 and Therakos, Inc., a foreign-owned, for-profit corporation that specializes in photopheresis products and services. The $106,524.00 firm-fixed price contract is for the provision of the CELLEX Photopheresis System, UVADEX medication, and associated procedural kits and supplies used for extracorporeal photopheresis treatments at VA...
- The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 9 awarded a Blanket Purchase Agreement (BPA) to Therakos, Inc., a foreign-owned for-profit corporation, to provide photopheresis light kits, UVADEX solution, and a photopheresis system. The BPA, which has a potential value of $32,704.56, was awarded on May 28, 2024 and has a completion date of May 31, 2024. Therakos is the prime contractor and there are no mentioned subcontractors....
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Therakos LLC, a foreign-owned for-profit corporation. The contract has a ceiling value of $111,708.00 and an ultimate completion date of September 22, 2025. The contract is for the provision of the CELLEX Photopheresis System procedural kits, UVADEX (methoxsalen) medication, and related medical equipment, which are used for extracorporeal...
This firm-fixed price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 9 to Therakos, Inc., a foreign-owned for-profit corporation, for the purchase of 18 photopheresis kits. The potential value of the award is $51,264.00 and the completion date is December 18, 2023. The contract is not associated with any socioeconomic set-aside programs. Therakos is a provider of photopheresis products and services to federal agencies, including the VA and the National Institutes of Health (NIH) Clinical Center, to enable extracorporeal photopheresis treatments at VA medical centers, the NIH Clinical Center, and other federal healthcare facilities. Therakos holds several active indefinite delivery vehicle (IDV) contracts with the VA, including a $3.49 million blanket purchase agreement awarded in 2023 to supply photopheresis light kits, UVADEX solution, and a photopheresis system through 2024, as well as a $750,000 multiple award schedule contract awarded in 2021 to deliver drugs, pharmaceuticals, and hematology products to the VA through January 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.3k | 9/7/23 |